Literature DB >> 15728199

GCMB mutation in familial isolated hypoparathyroidism with residual secretion of parathyroid hormone.

Caroline Thomée1, Steffen W Schubert, Jasmine Parma, Phu Quoc Lê, Said Hashemolhosseini, Michael Wegner, Marc J Abramowicz.   

Abstract

Isolated hypoparathyroidism is an uncommon metabolic disorder characterized by hypocalcemia and hyperphosphatemia, with absent or low levels of PTH. It may present as an apparently sporadic disorder or may be transmitted in families as a genetic trait. Mutations of the calcium-sensing receptor gene and of the preproPTH gene have been reported in occasional cases, and a mutation of the parathyroid-specific transcription factor GCMB gene has been reported in one familial case. We report a second family with isolated hypoparathyroidism and a GCMB mutation. The patients were two siblings from asymptomatic, first-cousin parents, indicating autosomal recessive inheritance. The mutation consisted of the substitution of a glycine residue with a serine at position 63 (G63S) in the DNA-binding GCM domain of GCMB. Functional studies in transfected cells showed that the mutation caused loss of GCMB function, as it abolished transactivation capacity, despite normal subcellular localization, protein stability, and DNA-binding specificity. Contrary to the previously reported family, our patients displayed low but clearly detectable levels of PTH in plasma. This residual hormone secretion probably results from a very small residual activity of the G63S mutant GCMB.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15728199     DOI: 10.1210/jc.2004-2450

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  20 in total

1.  Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research.

Authors:  John P Bilezikian; Aliya Khan; John T Potts; Maria Luisa Brandi; Bart L Clarke; Dolores Shoback; Harald Jüppner; Pierre D'Amour; John Fox; Lars Rejnmark; Leif Mosekilde; Mishaela R Rubin; David Dempster; Rachel Gafni; Michael T Collins; Jim Sliney; James Sanders
Journal:  J Bone Miner Res       Date:  2011-10       Impact factor: 6.741

2.  Gata3-deficient mice develop parathyroid abnormalities due to dysregulation of the parathyroid-specific transcription factor Gcm2.

Authors:  Irina V Grigorieva; Samantha Mirczuk; Katherine U Gaynor; M Andrew Nesbit; Elena F Grigorieva; Qiaozhi Wei; Asif Ali; Rebecca J Fairclough; Joanna M Stacey; Michael J Stechman; Radu Mihai; Dorota Kurek; William D Fraser; Tertius Hough; Brian G Condie; Nancy Manley; Frank Grosveld; Rajesh V Thakker
Journal:  J Clin Invest       Date:  2010-05-17       Impact factor: 14.808

3.  GCM2-Activating Mutations in Familial Isolated Hyperparathyroidism.

Authors:  Bin Guan; James M Welch; Julie C Sapp; Hua Ling; Yulong Li; Jennifer J Johnston; Electron Kebebew; Leslie G Biesecker; William F Simonds; Stephen J Marx; Sunita K Agarwal
Journal:  Am J Hum Genet       Date:  2016-10-13       Impact factor: 11.025

4.  Identification and characterization of C106R, a novel mutation in the DNA-binding domain of GCMB, in a family with autosomal-dominant hypoparathyroidism.

Authors:  Hyon-Seung Yi; Young Sil Eom; Ie Byung Park; Sangho Lee; Suntaek Hong; Harald Jüppner; Michael Mannstadt; Sihoon Lee
Journal:  Clin Endocrinol (Oxf)       Date:  2012-05       Impact factor: 3.478

5.  A Homozygous [Cys25]PTH(1-84) Mutation That Impairs PTH/PTHrP Receptor Activation Defines a Novel Form of Hypoparathyroidism.

Authors:  Sihoon Lee; Michael Mannstadt; Jun Guo; Seul Min Kim; Hyon-Seung Yi; Ashok Khatri; Thomas Dean; Makoto Okazaki; Thomas J Gardella; Harald Jüppner
Journal:  J Bone Miner Res       Date:  2015-06-08       Impact factor: 6.741

6.  Mutational analysis of GCMB, a parathyroid-specific transcription factor, in parathyroid adenoma of primary hyperparathyroidism.

Authors:  Michael Mannstadt; Emily Holick; Wenping Zhao; Harald Jüppner
Journal:  J Endocrinol       Date:  2011-06-03       Impact factor: 4.286

7.  Expression, function, and regulation of the embryonic transcription factor TBX1 in parathyroid tumors.

Authors:  Chiara Verdelli; Laura Avagliano; Vito Guarnieri; Filomena Cetani; Stefano Ferrero; Leonardo Vicentini; Edoardo Beretta; Alfredo Scillitani; Pasquale Creo; Gaetano Pietro Bulfamante; Valentina Vaira; Sabrina Corbetta
Journal:  Lab Invest       Date:  2017-09-18       Impact factor: 5.662

8.  A novel mutation in the GCM2 gene causing severe congenital isolated hypoparathyroidism.

Authors:  Daniel Doyle; Susan M Kirwin; Katia Sol-Church; Michael A Levine
Journal:  J Pediatr Endocrinol Metab       Date:  2012       Impact factor: 1.634

9.  Dominant-negative GCMB mutations cause an autosomal dominant form of hypoparathyroidism.

Authors:  Michael Mannstadt; Guylène Bertrand; Mihaela Muresan; Georges Weryha; Bruno Leheup; Sirish R Pulusani; Bernard Grandchamp; Harald Jüppner; Caroline Silve
Journal:  J Clin Endocrinol Metab       Date:  2008-06-26       Impact factor: 5.958

10.  Expression of parathyroid-specific genes in vascular endothelial progenitors of normal and tumoral parathyroid glands.

Authors:  Sabrina Corbetta; Marzia Belicchi; Federica Pisati; Mirella Meregalli; Cristina Eller-Vainicher; Leonardo Vicentini; Paolo Beck-Peccoz; Anna Spada; Yvan Torrente
Journal:  Am J Pathol       Date:  2009-07-30       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.